TA
PRNB

Teachers Advisors’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Teachers Advisors’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$263K Hold
7,743
– – ﹤0.01% 2773
2018
Q4 		$212K Buy
+7,743
New +$200K ﹤0.01% 2832

Other funds holding PRNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Teachers Advisors's PRNB Position: Q1 2019 in Review

Teachers Advisors held its Principia Biopharma Inc. Common Stock (PRNB) position steady in Q1 2019 at 7,743 shares worth $263K. The position accounts for ﹤0.01% of the portfolio, ranked #2773.

Teachers Advisors first reported a position in PRNB in Q4 2018 and has held it in 2 quarters since. 62 funds tracked by Wall St. Rank hold PRNB as of Q1 2019.

  • Teachers Advisors held 7,743 shares of Principia Biopharma Inc. Common Stock worth $263K as of Q1 2019.
  • Teachers Advisors left its Principia Biopharma Inc. Common Stock share count unchanged in Q1 2019.
  • Principia Biopharma Inc. Common Stock made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2773 holding.
  • Teachers Advisors first reported a position in Principia Biopharma Inc. Common Stock in Q4 2018 and has held it in 2 quarters since.
  • 62 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.